Pimavanserin OverviewPimavanserin (ACP-103; BVF-036), sold under the brand name Nuplazid, is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being researched for the treatment of Alzheimer’s disease psychosis, schizophrenia, agitation, and major depressive disorder. Unlike other antipsychotics, pimavanserin is not a dopamine receptor antagonist. Contents 1 Pharmacology 1.1 Pharmacodynamics 2 History 2.1 De...
Read more Pimavanserin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pimavanserin
Recent Pimavanserin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 34mg
- Tablet: 10mg, 17mg
- Unknown: Unknown
Other drugs which contain Pimavanserin or a similar ingredient: (1 result)
- NUPLAZID Pimavanserin